These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1196082)

  • 1. [Demonstration of the effect of pentoxyphylline in arterial circulation disorders (double-blind study using Trental 400)].
    Schubotz R
    Med Welt; 1975 Oct; 26(41):1884-5. PubMed ID: 1196082
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
    Schafé MK
    Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of peripheral arterial circulation disorders using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Denck H
    Arzneimittelforschung; 1973 Apr; 23(4):571-3. PubMed ID: 4740236
    [No Abstract]   [Full Text] [Related]  

  • 4. [Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
    Stiegler H; Diehm C; Grom E; Martin M; Mörl H; Rudofsky G; Vogelberg KH
    Vasa Suppl; 1992; 35():164-6. PubMed ID: 1481031
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of peripheral occlusive vascular disease with pentoxifylin (author's transl)].
    Traumann KJ
    Med Klin; 1976 Mar; 71(11):465-8. PubMed ID: 1263995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)].
    Kellner H
    MMW Munch Med Wochenschr; 1976 Oct; 118(43):1399-1402. PubMed ID: 825745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
    Creutzig A; Caspary L; Alexander K
    Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with a new vasotherapeutic agent in diseases of the fundus (author's transl)].
    Fellner R; Simon A
    Klin Monbl Augenheilkd; 1973 Jun; 162(6):811-7. PubMed ID: 4745900
    [No Abstract]   [Full Text] [Related]  

  • 9. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G; Rotatori P; Gaggi S; Barone A; Pupita F
    Minerva Cardioangiol; 1988 Jun; 36(6):319-22. PubMed ID: 3211330
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with a new xanthine derivative in central and peripheral blood circulation disorders].
    Hirsch W; Woschée GJ
    Ther Ggw; 1971 Nov; 110(11):1668 passim. PubMed ID: 5158649
    [No Abstract]   [Full Text] [Related]  

  • 11. [Objective data on the action of piribedil in disorders of the peripheral arterial circulation].
    Royer RJ
    Minerva Med; 1976 May; 67(25):1656-61. PubMed ID: 778667
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ozone therapy, a new method of treating chronic obliterating arteriopathies].
    Ionescu G; Pitea P; Blaj A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(3):207-13. PubMed ID: 2931752
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pilot study of the effect of intravenous prostavasin therapy of inpatients with diabetes mellitus and IIb arterial occlusive disease].
    Rosak C; Hofmann U; König P; Nitsche GB
    Vasa Suppl; 1991; 33():339-40. PubMed ID: 1788748
    [No Abstract]   [Full Text] [Related]  

  • 14. [Controlled study with nicergoline and placebo in cerebral and peripheral vascular insufficiency in the aged].
    Cascone A; Liverta C; Pollini C
    Minerva Cardioangiol; 1978; 26(1-2):95-100. PubMed ID: 347330
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of peripheral circulation disorders of lower extremities with Flunarizine and papaverine].
    Brugmans J; Jageneau A; Adriaensen H
    Med Welt; 1977 Jun; 28(23):1056-64. PubMed ID: 886962
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ophthalmological experiences with the xanthine compound BL 191 (author's transl)].
    Heinsius E; Flamm P
    Med Klin; 1973 Nov; 68(47):1540-8. PubMed ID: 4781096
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug-induced improvement of blood flow properties. Effective principle in the treatment of arterial occlusive diseases].
    Hess H; Franke I; Jauch M
    Fortschr Med; 1973 Jun; 91(17):743-8. PubMed ID: 4577522
    [No Abstract]   [Full Text] [Related]  

  • 18. [Restless legs and crampi in the night. Double blind study with Circonyl in patients with defective peripheric arterial circulation (author's transl)].
    Hürlimann F
    Schweiz Rundsch Med Prax; 1974 Feb; 63(7):194-5. PubMed ID: 4605921
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa Suppl; 1992; 35():39-41. PubMed ID: 1481056
    [No Abstract]   [Full Text] [Related]  

  • 20. [Conservative therapy of arterial occlusive diseases. Double-blind study on the effect of butalamine hydrochloride].
    Seboldt H
    Fortschr Med; 1980 Feb; 98(7):257-60. PubMed ID: 6767648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.